MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202421015355 A) filed by Alkem Laboratories Limited, Maharashtra, on March 1, 2024, for 'pharmaceutical composition comprising tofacitinib.'
Inventor(s) include Ashish Sehgal; Satyanarayana Tallam; Madhusudan Sudhakar Hanchate; and Ujjwal Rakeshsingh Rana.
The application for the patent was published on Sept. 5, under issue no. 36/2025.
According to the abstract released by the Intellectual Property India: "Pharmaceutical composition comprising Tofacitinib The present invention relates to extended release composition of Tofacitinib or salt thereof, and process of manufacture thereof. Specifically, the present invention relates to the extended release composition comprising Tofacitinib or salt thereof, cellulosic polymer and pharmaceutically acceptable excipients. The invention also relates to the use of treatment of rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC) and polyarticular course juvenile idiopathic arthritis (pcJIA)."
Disclaimer: Curated by HT Syndication.
